Social Media Press Releases
RSSShowing Press Releases with Tag: influenza virus
9/07/2007
MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
» read more7/03/2007
MedImmune Begins Dosing Children Six Months to 24 Months of Age in Phase 1 Study of Vaccine to Help Prevent Two of the Most Common Viral Causes of Childhood Respiratory Illness
» read more6/14/2007
Medimmune Is Awarded Contract By U.S. Department Of Health and Human Services to Retrofit Manufacturing Facilities For Production of Pandemic Influenza Vaccines
» read more5/08/2007
Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings
» read more3/21/2007
Research Results on FluMist(R) Presented at National Association of Pediatric Nurse Practitioners Conference
» read more3/16/2007
MedImmune Leases Human Genome Sciences Facility to Expand Cell Culture Influenza Vaccine Manufacturing Capabilities
» read more2/14/2007
Study Published in The New England Journal of Medicine: 55 Percent Fewer Cases of Flu in Young Children Vaccinated With FluMist(R) Vs. Flu Shot
» read more12/13/2006
School-Based Vaccination Study With FluMist(R) Lowers Rates of Flu Among School Community and Families
» read more12/06/2006
MedImmune Reconfirms 2009 Financial Targets of $2 Billion in Revenues and $2.00 in Earnings Per Diluted Share, Excluding Share-Based Compensation Expense, at 2006 Analyst Day
» read more11/09/2006
MedImmune Files Investigational New Drug Application for Cell Culture-Based Influenza Vaccine
» read more10/13/2006
